PreveCeutical Medical (XCNQ:PREV) Total Stockholders Equity : C$-5.40 Mil (As of Sep. 2023)

View and export this data going back to 2016. Start your Free Trial

What is PreveCeutical Medical Total Stockholders Equity?

PreveCeutical Medical's Total Stockholders Equity for the quarter that ended in Sep. 2023 was C$-5.40 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. PreveCeutical Medical's Book Value per Share for the quarter that ended in Sep. 2023 was C$-0.01. The ratio of a company's debt over equity can be used to measure how leveraged this company is. PreveCeutical Medical's Debt-to-Equity for the quarter that ended in Sep. 2023 was -0.70.

PreveCeutical Medical Total Stockholders Equity Historical Data

The historical data trend for PreveCeutical Medical's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PreveCeutical Medical Total Stockholders Equity Chart

PreveCeutical Medical Annual Data

Trend

Jul15

Jul16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Total Stockholders Equity

Get a 7-Day Free Trial

-2.29

-4.49

-3.60

-4.10

-4.64

PreveCeutical Medical Quarterly Data
	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Sep23
Total Stockholders Equity	Get a 7-Day Free Trial															-4.10	-4.34	-4.52	-4.64	-5.40

PreveCeutical Medical (XCNQ:PREV) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

PreveCeutical Medical's Book Value per Share for the quarter that ended in Sep. 2023 is

Book Value per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(-5.396	-	0)	/	535.303
	=	-0.01

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

PreveCeutical Medical's Debt-to-Equity for the quarter that ended in Sep. 2023 is

Debt-to-Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(3.778	+	0)	/	-5.396
	=	-0.70

PreveCeutical Medical Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of PreveCeutical Medical's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

PreveCeutical Medical (XCNQ:PREV) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » PreveCeutical Medical Inc (XCNQ:PREV) » Definitions » Total Stockholders Equity

Comparable Companies

Traded in Other Exchanges

PRVCF:USA 18H:Germany

Address

885 Cambie Street, Suite 2500, Vancouver, BC, CAN, V6B 0R6

Website

https://www.preveceutical.com

PreveCeutical Medical Inc is a health sciences company. Its principal business activity is the development of innovative options for preventive and curative therapies utilizing organic and nature-identical products. It is engaged in licensing, branding, and marketing nutraceutical and wellness products.

PreveCeutical Medical (XCNQ:PREV) Headlines

No Headlines